The effects of IL-10 gene polymorphism on serum, and gingival crevicular fluid levels of IL-6 and IL-10 in chronic periodontitis by Toker, Hulya et al.
J Appl Oral Sci.
Abstract
Submitted: May 17, 2017
Modified: August 14, 2017
Accepted: August 22, 2017
The effects of IL-10 gene 
polymorphism on serum, and gingival 
crevicular fluid levels of IL-6 and IL-10 
in chronic periodontitis
Objective: Anti-inflammatory cytokines play a crucial role in periodontitis 
by inhibiting synthesis of pro-inflammatory cytokines. The purpose of this 
study was to evaluate the effect of interleukin-10 (-597) gene polymorphism 
and genotype distributions on chronic periodontitis (CP) development and 
IL-6 and IL-10 levels in gingival crevicular fluid (GCF) and serum before 
and after non-surgical periodontal treatment. Material and Methods: The 
study population consisted of 55 severe generalized CP patients as CP group 
and 50 healthy individuals as control group. Plaque index, gingival index, 
probing depth and clinical attachment level were recorded and GCF and blood 
samples were taken at both the baseline and the sixth week after non-surgical 
periodontal treatment. PCR-RFLP procedure was used for gene analyses and 
cytokine levels were measured via ELISA. Results: IL-10 genotype distribution 
was significantly different between CP and control groups (p=0.000, OR:7, 
95%CI, 2.83-60.25). Clinical measurements significantly improved in the 
CP group after periodontal treatment (p<0.05). Periodontal treatment 
significantly decreased GCF IL-6 and IL-10 levels. No significant difference 
was found in clinical parameters between IL-10 AA and AC+CC genotypes at 
both the baseline and the sixth week (p>0.05). Sixth week GCF IL-10 levels 
were significantly lower in patients carrying IL-10 AC+CC genotype compared 
to the patients carrying IL-10 AA genotype (p<0.05). Serum IL-6 and IL-10 
levels were lower in patients carrying the IL-10 AA genotype compared to 
patients with IL-10 AC+CC genotype, but the difference was not significant 
(p>0.05). Conclusion: IL-10 AA genotype carriers had lower IL-6 and IL-6/10 
levels in serum; however, GCF IL-6/10 levels were similar in both genotypes. 
Within the limitations of our study, a possible association between IL-10(-
597) gene polymorphism and CP might be considered.
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Introduction
Chronic periodontitis (CP) is the inflammatory 
and infectious disease of the soft and hard tissues 
around teeth. Etiopathogenesis of the disease 
involves many factors such as environmental and 
genetic factors22. Cytokines are the most important 
candidates for involvement of gene polymorphisms 
in CP development; possible associations between 
CP and certain gene polymorphisms were suggested7. 
The structure of a protein and/or its expression 
might change by polymorphism of the specific 
gene, thus, innate and adaptive immunity may be 
compromised13,27. Therefore, gene polymorphisms 
might have a deterministic importance in disease 
outcome.
One of the most important factors responsible for 
periodontal destruction is the upregulation of pro-
inflammatory cytokines. Interleukin-6 (IL-6), as one of 
these pro-inflammatory cytokines, was reported to be 
an effective stimulator of osteoclast differentiation and 
bone resorption21. Along with CP, several inflammatory 
diseases were also associated with elevated levels 
of IL-612,17. On the other hand, anti-inflammatory 
cytokines such as IL-10 can restore balance by 
inhibiting synthesis of pro-inflammatory cytokines 
(IL-1, IL-6, TNF-alpha) and stimulating protective 
antibody production20,26. For this reason, IL-10 gene 
polymorphism might contribute to periodontitis 
development.
The gene encoding human IL-10 is located on 
chromosome one (1q31-32). IL-10 three biallelic 
polymorphisms within the IL-10 promoter region, at 
positions -1087, -824, and -597 from the transcription 
initial site, have also been identified23. Although 
decreased IL-10 levels with IL-10 promotor gene 
polymorphism were reported, studies evaluating 
the relationship between this single nucleotide 
polymorphisms (SNPs) and CP reported conflicting 
results3,8,11,20,23.
Several researches on the clinical utility of cytokine 
genotyping for periodontal disease were conducted, but 
the genetic knowledge of periodontitis pathogenesis 
and effects on treatment results is still limited. 
Previously, we reported that IL-6 (-174) GG genotype 
caused an increase in GCF IL-10 levels without 
affecting periodontal treatment outcomes and we also 
found that SNPs in IL-6 (-174) and IL-10 (-597) were 
associated with generalized aggressive periodontitis 
(GAgP)18. However, there is no information regarding 
the ratio of inflammatory markers (IL-6/IL-10) in 
different genotype distribution of IL-10 gene in chronic 
periodontitis. Therefore, the aim of our study was 
to assess the IL-10 -597 SNPs in CP patients and to 
evaluate the effect of polymorphisms on non-surgical 
periodontal therapy and serum and GCF cytokine (IL-
6 and IL-10) levels. Secondly, a possible association 
between IL-10 genotypes and local and systemic 
inflammatory status presented as the ratio of IL-6/
IL-10 was investigated.
Material and methods
Study population
A total of 105 participants were involved in this 
study. CP group consisted of 55 chronic periodontitis 
patients (CP group) and control group consisted of 
50 healthy volunteers (HC group). All participants 
were systemically healthy and never smoked. Ethical 
approval was provided by the Ethical Committee of 
Human Researches of Cumhuriyet University Faculty 
of Medicine, according to the Helsinki declarations 
(2012-02/035). All participants were informed and 
signed the informed consent form.
Exclusion criteria were: presence of conservative 
or prosthetic restorations in the anterior region, 
systemic disease, obesity, pregnancy or lactation, 
antibiotic or anti-inflammatory drug use within 
three months, requirement of antibiotic prophylaxis, 
infectious diseases such as hepatitis and HIV infection, 
chemotherapy, and periodontal treatment within six 
months.
Chronic periodontitis was diagnosed based on 
clinical examination. 30% of total teeth in CP patients 
had CAL values higher than 5 mm1. Periodontally 
healthy individuals had no alveolar bone loss in 
radiographs. Control group also had full mouth 
probing depth with less than 3 mm and gingival index 
score lower than 1. In all participants, plaque index 
(PI), gingival index (GI), probing depth (PD) and 
clinical attachment level (CAL) were measured at six 
sites around teeth15 and recorded by one calibrated 
periodontist.
All CP patients received non-surgical periodontal 
therapy. Oral hygiene instructions were given and 
scaling and root planing was performed within 10 
days by one specialized physician (E.P.G.). Non-
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surgical periodontal therapy was performed under 
local anesthesia in four sessions, one quadrant in each 
session with site-specific gracey curettes (Hu-Friedy, 
Chicago, IL, USA). PI, GI, PD, CAL measurements were 
recorded and blood samples were taken at both the 
baseline and the sixth week of study.
GCF sampling
Single-rooted teeth with moderate PD and CAL 
were chosen for GCF sampling in CP patients and 
equivalent teeth with healthy periodontium in HC 
group. GCF sampling was performed in proximal 
sites of the chosen tooth with a paper strip (ProFlow 
Inc., Amityville, NY, USA). The strip was placed into 
periodontal pocket in CP patients and gingival sulcus 
in HC group until a mild resistance was felt and held 
in place for 30 seconds14. Mechanical trauma and 
contamination of strip with saliva and/or blood were 
avoided. Contaminated strips were excluded and 
sampling was repeated 30 minutes later. All strips were 
placed into eppendorf tubes individually and kept at 
-80°C until ELISA analysis.
Serum collection
To obtain serum samples, 5 mL of venous blood 
from antecubital vein were driven from each participant 
and placed into biochemical tubes containing an 
anticoagulant agent. Blood samples in tubes were 
allowed to rest for 30 minutes and then centrifuged 
at 6,000 rpm for 10 minutes. Serum was separated 
from tube and placed into eppendorf tubes. All serum 
samples were kept at -80°C until analysis.
ELISA analysis
We added 100 µL of phosphate buffer solution 
into eppendorf tubes containing paper strips and 
mixed via vortex for a minute. IL-6 and IL-10 levels 
in GCF and serum samples were determined via ELISA 
kits (Invitrogen, Cambrillo, USA) according to the 
manufacturer’s protocol. After the procedure, plates 
were read on a spectrometer at 450 nm wavelength. 
The results were converted to numeric values by using 
standard curves.
DNA extraction and genotyping
The study protocol was carried out about our 
previous study7. For DNA extraction and genotyping, 
2 mL of blood from the antecubital vein was driven 
from all participants and placed into biochemical 
tubes containing sodium EDTA. Tubes were then kept 
at -80°C until the genetic analysis day. A commercial 
kit (Invitrogen, Cambrillo, USA) was used for DNA 
extraction according to the manufacturer’s instructions.
IL-10 gene polymorphism was evaluated via PCR-RFLP 
by analyzing IL-10 gene at position -597. Table 1 presents the 
primer sequences used for primer pairs.
Amplification was performed via PCR (PTC-200 
Thermal Cycler, MJ Research, Watertown, MA, USA) 
by using specific primers. PCR reaction mixtures (50 
Nl) consisted of 5 Nl×10 PCR buffer, 0.2 mM each 
dNTP, 10 pmol of each primer (forward and reverse 
control and specific allele), 1.5 mM MgCl2, 200 ng of 
genomic DNA, 0.5 U Taq DNA polymerase (Fermantes, 
Maryland, USA) and internal control primers.
Afterwards, the amplification protocol was 
conducted as follows for IL-10 (-597) A/C: 1) Pre-PCR 
(94°C for 3 min), 2) PCR (35 cycles: 94°C for the 30 
s, 48°C for 40 s, 72°C for 40 s); and 3) Elongation 
(72°C for 5 min). After these procedures, DNA was 
digested with restriction fragments and separated by 
size with the use of electrophoresis. RFLP amplification 
protocols were directed with the restriction enzyme 
RsaI. The fragments were also visualized on agarose 
gel at 3%. The expected results were at position -597, 
where A is present, leading to fragments of 42, 66, 
232, and 240 bp in length, or 42, 232 and 306 bp, 
where C is present. In heterozygote individuals, the 
length of (A/C) were 42, 66, 232, 240 and 306 bp.
Statistical evaluation
We performed statistical analysis using SPSS 
15.0 (SPSS Inc., Chicago, IL, USA). Demographic 
data and clinical parameters were expressed as a 
mean±standard deviation. Genotype frequencies were 
defined by direct counting and allele frequencies were 
calculated from the observed number of genotypes. 
The frequencies of alleles and genotypes in patients 
with CP and controls were compared with the use of 
chi-square test and 95% confidence intervals. After 
the normality test, Mann-Whitney U and Wilcoxon tests 
were used. Gene polymorphisms were examined by 
logistic regression analysis while adjusting for potential 
confounding factors, including age and gender. The 
sample size was calculated for a significance level of 
0.05 and the required sample size was 55 in the CP 
group, giving a statistical power of 80%23.
Genotype distributions of the groups and deviation 
of genotype frequencies from Hardy-Weinberg 
equilibrium were evaluated with chi-square test. 
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Association was determined with odds ratios (ORs) 
and 95% confidence intervals. A p-value of <0.05 was 
considered statistically significant.
Results
Clinical parameters
Four participants from the CP group did not want 
periodontal treatment and were excluded from study. 
The CP group consisted of 17 men and 34 women 
(aged 20 to 46 years; mean age: 33.4±6.0). The 
healthy control group consisted of 17 men and 33 
women (aged 23 to 46 years; mean age: 33±6.5). 
There was no significant difference in age and sex 
distributions in the groups (p>0.05).
Periodontal treatment decreased all clinical 
parameters in the CP group at the 6th week compared 
to the baseline (p<0.05) (Table 1), but clinical 
parameters were still higher at the 6th week compared 
to the HC group (p<0.05).
Genotype distribution
IL-10 genotype frequencies of the groups showed 
disequilibrium according to Hardy-Weinberg (p<0.05). 
However, the allele frequencies of the IL-10 gene in 
study groups were in accordance with Hardy-Weinberg 
equilibrium (p>0.05).
IL-10 (-597) A/C genotype distribution was 
different between groups (p<0.05) (Table 2). In 
the CP group, IL-10 AA genotypes were associated 
to risk of periodontitis development 7 times higher 
in comparison with IL-10 AC/CC genotype with a 
statistically significant risk coefficient (OR:7, 95%CI, 
2.83-60.25, p<0.05). The genotype distribution in the 
CP group was 35.3% for the AA genotype, 52.9% for 
the AC genotype, and 13.2% for the CC genotype. 
Also, allele frequencies were similar in the CP and 
healthy control groups (p>0.05).
Biochemical parameters
At the 6th week, IL-6 and IL-10 levels in GCF were 
lower than baseline in CP group (p<0.05) (Table 3). 
Both baseline and 6th week levels of IL-6 in GCF of 
CP group were higher than those of the HC group 
(p<0.05). However, unlike GCF levels, serum levels 
of IL-6 and IL-10 in the CP group did not change after 
periodontal treatment (p>0.05). In the comparison 
between groups, serum cytokine levels were higher in 
the CP group than those of the control group (p<0.05). 
According to the ratio of IL-6/IL-10, serum and GCF 
IL-6/IL10 levels were significantly higher in the CP 
group than those of the control group (p<0.05). 
However, baseline and 6th week values of IL-6/IL-10 
ratio in GCF and serum were similar (p>0.05).
CP
n=51
C
n=50
P-value
IL-10(-597)
CC 7(13.2) 3(6)
AC 27(52.9) 45(90) 0.000*
AA 18(35.3) 2(4)
Allelic frequencies
IL-10(-597)
C 39(38.2) 51(51) 0.089
A 63(61.7) 49(49)
*p<0.05
Table 2- Allelic and genotypic frequencies observed in patients 
and healthy controls regarding the IL-10 (-597) G/C gene 
polymorphism. *p<0.05
CP C
PI Baseline 1.9±0.6
6th week 0.5±0.5a 0.1±0.3
GI Baseline 2±0.3
6th week 0.7±0.6a 0.1±1.3
PD Baseline 5.4±0.6
6th week 3±1a 2±0.7
CAL Baseline 10±2.1
6th week 8±2.1a
Table 1- Clinical parameters at baseline and 6-week for study 
groups (mean ±SD)
a p<0.05
CP C
GCF
IL-6
Baseline 45.1±58.2b
6th week 22.8±35.6a,b 14.5±28.1
IL-10
Baseline 17.8±28.1
6th week 5.9±6.8a 6.9±13.3
IL-6/IL-10
Baseline 3.6±5.9b
6th week 4.6±8.3b 1.6±4.5
SERUM
IL-6
Baseline 23.9±63b
6th week 23.7±61.5b 3.1±11.4
IL-10
Baseline 3.3±6.8b
6th week 3.7±8.9b 0.8±2.6
IL-6/IL-10
Baseline 1.2±3.1b
6th week 2±4.3b 0.5±2.9
Table 3- Gingival crevicular fluid (GCF) and serum IL-6, IL-10 
levels and IL-6/IL-10 ratio at baseline and 6-week (pg/30 s, mean 
±SD)
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We evaluated the changes in clinical and biochemical 
parameters in the CP group after categorizing patients 
according to IL-10 genotype distribution (IL-10 AA and 
AC+CC). Periodontal treatment provided significant 
improvements in both genotypes (p<0.05) (Table 4). 
However, clinical parameters between IL-10 AA and 
AC+CC genotypes were similar in both baseline and 
6th week (p>0.05) (Table 5).
GCF IL-10 levels at the 6th week in patients 
carrying IL-10 AC+CC genotype significantly decreased 
(p<0.05) (Table 4). In contrast, GCF and serum IL-6 
levels in patients carrying the IL-10 AA genotype were 
not statistically different (p>0.05). Serum IL-10 levels 
in patients carrying IL-10 AA genotypes were not 
different from those of the IL-10 AC+CC genotypes 
at either baseline or 6th week (p>0.05). The ratios of 
IL-6/IL-10, especially in serum, were lower in patients 
with IL-10 AA genotypes compared to IL-10 AC+CC 
genotypes (p<0.05).
Periodontal disease susceptibility in the CP group 
was evaluated with logistic regression analysis of IL-
10 AA genotypes after adjustment of age and sex. 
Genotype diversity was not affected by either age 
or sex.
Discussion
The complexity of cytokine network, together 
with gene polymorphisms of these cytokines, aids in 
uncovering the molecular mechanisms of inflammatory 
diseases, such as periodontal diseases. In this way, 
our study evaluated the role of anti-inflammatory (IL-
10) and proinflammatory cytokines (IL-6) in chronic 
periodontitis patients. Correlation of these results with 
the gene polymorphism of IL-10 was also performed. 
As a result, we found that IL-10 AA genotypes were 
associated with chronic periodontitis and IL-10 AA 
genotype carriers showed lower IL-6/IL-10 levels in 
serum.
In this study, patients with the IL-10 AA genotype 
had a high susceptibility to chronic periodontitis. 
Similarly to our results, Sumer, et al.12 (2007) reported 
that the IL-10 gene polymorphism at position -597 
seems to be associated with severe generalized CP. 
Association of SNPs in vascular endothelial growth 
factor (VEGF) , IL-6, IL-10, IL-1beta, interferon alpha, 
TNF-alpha genes with immunoregulatory function 
revealed that C allele of VEGF, an allele of IL-10 and 
GG genotype of TNF-alpha, was individually associated 
with chronic periodontitis10. Although A alleles were 
higher in CP groups in this study, our results showed 
that the allele frequencies did not differ between 
chronic periodontitis and healthy control groups. 
However, Jaradat, et al.14 (2012) showed that the A 
positive allele genotypes (CA/AA) at position -597 
GCF SERUM
IL6 IL10 IL6/IL10 IL6 IL10 IL6/IL10
IL-10 Baseline 29,67±27.75 11.97±8.5 2.07±3.6 1.79±1.93 0.51±1.02 0.2±0.2
AA 6th week 9.43±7.99 8.17±10.9 4.36±5.34 0.72±0.61 0.09±0.18 0.43±0.51
IL-10 Baseline 47.5±61.63 18.74±30 3.92±6.2 27.32±67.2 3.77±7.25 1.41±3.33
AC+CC 6th week 24.95±37.9 5.65±6.29a 4.65±8.74 27.34±65.53 4.27±9.47 2.27±4.65
ap<0.05 vs. baseline
Table 4- Gingival crevicular fluid (GCF) and serum IL-6, IL-10 levels and IL-6/IL-10 ratio at baseline and 6-week according to IL-10 
genotypes (pg/30 s, Mean ±SD). a p<0.05 vs baseline
Clinical 
parameters
IL-10
AA AC+CC
PI
Baseline 1.75±0.5 1.9±0.6
6th week 0.25±0.5 0.5±0.5
P=0.01* P=0.00*
GI
Baseline 2±0 2±0.3
6th week 0.75±0.9 0.7±0.5
P=0.08 P=0.000*
PD
Baseline 5.2±0.5 5.4±0.6
6th week 3±0.8 3±1
P=0.00* P=0.000*
CAL
Baseline 8.7±2.2 10.2±2
6th week 7.2±1.5 8.1±2.2
P=0.05* P=0.000*
*p<0.05, vs. 6th week
Table 5- Clinical parameters in chronic periodontitis (CP) group 
distributed by IL-10 genotypes (mean ±SD)
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seemed to increase the risk of chronic periodontitis. 
Unlike our results, Gonzales, et al.8 (2002) reported 
that IL-10 loci were not associated with either CP or 
AgP. Supporting Gonzales, et al.13 (2002), Reichert, 
et al.22 (2008) researched the German, Atanasovska-
Stojanovska, et al.23 (2012), the Macedonian, and 
Brett, et al.24 (2005), the English Caucasians, and they 
found no association between CP patients and IL-10 
-597 gene polymorphisms. Dissimilarity between the 
studied populations, number of subjects, differences 
in disease definition and experimental protocol (such 
as real-time PCR) might be the reason of dissimilarity 
among studies.
IL-10 is an important contributor to the pathogenesis 
of periodontal diseases2,19. Current results revealed 
that clinical outcomes were improved and IL-10 levels 
in GCF decreased after periodontal therapy. Similar 
to our results, several studies reported that serum 
IL-10 levels in patients with chronic periodontitis are 
higher than in periodontally healthy individuals6,9. In 
addition, the results of our study are different from 
the findings of Passoja, et al.29 (2010) which showed 
that the control group had significantly higher levels 
of IL-10 than the periodontitis groups.
IL-10 suppresses the production of IL-1, tumor 
necrosis factor- (TNF-)α, IL-6, IL- 8, IL-12, and IL-18. 
Also, similar to our results, IL-6 levels were elevated 
in periodontitis patients16,17 and decreased after 
successful periodontal therapy4,5. However, Reis, et 
al.33 (2014) reported that non-surgical periodontal 
therapy resulted in a decrease in IL-1, IL-1β, and IL-6 
GCF levels, but not in IL-10 or TNF levels. In contrast, 
GCF IL-10 levels were associated with IL-6 levels in 
this study. Moreover, our results demonstrated that 
GCF and serum IL-6/IL-10 levels were higher in the 
CP group compared to healthy controls, which reflect 
local and systemic inflammation in periodontitis.
In addition, we evaluated whether the IL-10 
genotypes could influence the levels of IL-6 and IL-
10. IL-10 promoter gene polymorphisms have been 
associated with decreased serum IL-10 production24. 
However, IL-10 gene polymorphism and the amount 
of IL-10 depend on many factors, such as cell type, 
stimulation of time, kind of stimulus and the presence 
of other cytokines25. A recent study demonstrated 
that the A allele of IL-10-592 SNP was more prevalent 
in the CP group. It was also found that IL-10-592 
SNP was functional and associated with lower levels 
of IL-10, TIMP-3 and OPG m-RNA expressions in 
diseased periodontal tissues3. Similarly, patients with 
AA genotypes presented lower levels of IL-10 and 
IL-6/IL-10 ratio in serum than those of the AC+CC 
genotype carriers in our study, but this reduction is 
not statistically significant. On the other hand, GCF 
IL-10 levels decreased after treatment in IL-10 AC+CC 
genotype carriers, but did not change in patients with 
AA genotypes.
In this study, we did not assess the haplotype 
analyses for this gene locus, which may be considered 
a shortcoming. Also, another limitation of this study 
is the low number of subjects included. However, we 
excluded periodontitis smoker patients because of the 
effects of smoking on the immune system.
Conclusion
In conclusion, this study demonstrated that IL-
10 -597 AA genotype appeared to be a risk factor 
for chronic periodontitis. Furthermore, genetic 
polymorphisms in the IL-10 gene might be useful as a 
marker to diagnose susceptibility to CP. On the other 
hand, an important finding of this study is that IL-10 
AA genotype may tend to reduce IL-6 production or 
contribute to the inflammatory status, along with 
decreased GCF IL-10 levels. Nonetheless, further 
studies are needed to elucidate the mechanisms 
involved in cytokine gene polymorphisms and their 
production in periodontal disease.
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